GB9020927D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9020927D0
GB9020927D0 GB909020927A GB9020927A GB9020927D0 GB 9020927 D0 GB9020927 D0 GB 9020927D0 GB 909020927 A GB909020927 A GB 909020927A GB 9020927 A GB9020927 A GB 9020927A GB 9020927 D0 GB9020927 D0 GB 9020927D0
Authority
GB
United Kingdom
Prior art keywords
alkyl
phenyl
naphthyl
group
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909020927A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB909020927A priority Critical patent/GB9020927D0/en
Publication of GB9020927D0 publication Critical patent/GB9020927D0/en
Priority to DK91916973T priority patent/DK0550550T3/da
Priority to ES91916973T priority patent/ES2203609T3/es
Priority to HK98113476.9A priority patent/HK1012356B/en
Priority to AT91916973T priority patent/ATE245157T1/de
Priority to CA002092431A priority patent/CA2092431C/en
Priority to JP3515796A priority patent/JP2831464B2/ja
Priority to PCT/GB1991/001629 priority patent/WO1992005174A1/en
Priority to DE69133295T priority patent/DE69133295T2/de
Priority to AU86244/91A priority patent/AU652187B2/en
Priority to EP91916973A priority patent/EP0550550B1/en
Priority to IE335291A priority patent/IE913352A1/en
Priority to MX9101236A priority patent/MX9101236A/es
Priority to PT99028A priority patent/PT99028B/pt
Priority to ZA917606A priority patent/ZA917606B/xx
Priority to NZ239915A priority patent/NZ239915A/xx
Priority to TW080107616A priority patent/TW240227B/zh
Priority to KR1019930700921A priority patent/KR100200438B1/ko
Priority to CY0300069A priority patent/CY2387B1/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB909020927A 1990-09-26 1990-09-26 Pharmaceuticals Pending GB9020927D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB909020927A GB9020927D0 (en) 1990-09-26 1990-09-26 Pharmaceuticals
ES91916973T ES2203609T3 (es) 1990-09-26 1991-09-23 Derivados de 3,9-diazabiciclo(3,3,1)nonan-7-ilo, procedimiento e intermedios para su preparacion y composiciones farmaceuticas que los contienen.
DE69133295T DE69133295T2 (de) 1990-09-26 1991-09-23 3,9-diazabicyclo-[3.3.1]-nonanylderivate, verfahren und intermediate für ihre darstellung und sie enthaltende pharmazeutische zusammensetzungen
EP91916973A EP0550550B1 (en) 1990-09-26 1991-09-23 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
HK98113476.9A HK1012356B (en) 1990-09-26 1991-09-23 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
AT91916973T ATE245157T1 (de) 1990-09-26 1991-09-23 3,9-diazabicyclo-(3.3.1)-nonanylderivate, verfahren und intermediate für ihre darstellung und sie enthaltende pharmazeutische zusammensetzungen
CA002092431A CA2092431C (en) 1990-09-26 1991-09-23 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
JP3515796A JP2831464B2 (ja) 1990-09-26 1991-09-23 ３，９−ジアザビシクロ（３．３．１）ノナン−７−イル誘導体、その製造方法およびその製造用中間体ならびにそれを含有する医薬組成物
PCT/GB1991/001629 WO1992005174A1 (en) 1990-09-26 1991-09-23 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
DK91916973T DK0550550T3 (da) 1990-09-26 1991-09-23 3,9-Diazabicyclo(3.3.1)nonan-7-yl-derivater, fremgangsmåde og intermediater til fremstilling af disse, og farmaceutiske præparater, hvori de er indeholdt
AU86244/91A AU652187B2 (en) 1990-09-26 1991-09-23 3,9-diazabicyclo (3.3.1) nonan-7-YL derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
IE335291A IE913352A1 (en) 1990-09-26 1991-09-24 Pharmaceuticals
NZ239915A NZ239915A (en) 1990-09-26 1991-09-24 Endo-3,9-diazabicyclo(3.3.1)nonan-7-yl derivatives; medicaments, preparation, and use
MX9101236A MX9101236A (es) 1990-09-26 1991-09-24 Procedimiento para la preparacion de compuestos azabiciclicos
PT99028A PT99028B (pt) 1990-09-26 1991-09-24 Processo para a preparacao de compostos azabiciclicos
ZA917606A ZA917606B (en) 1990-09-26 1991-09-24 Pharmaceutical azagranatane derivatives
TW080107616A TW240227B (https=) 1990-09-26 1991-09-26
KR1019930700921A KR100200438B1 (ko) 1990-09-26 1993-03-26 3,9-디아자비시클로(3,3.1) 노난-7-일 유도체, 이들의 제조를 위한 방법 및 중간체 및 이들을 함유한 제약학적 조성물
CY0300069A CY2387B1 (en) 1990-09-26 2003-10-17 3,9-Diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation andpharmaceutical compositions containing them.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909020927A GB9020927D0 (en) 1990-09-26 1990-09-26 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB9020927D0 true GB9020927D0 (en) 1990-11-07

Family

ID=10682769

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909020927A Pending GB9020927D0 (en) 1990-09-26 1990-09-26 Pharmaceuticals

Country Status (18)

Country Link
EP (1) EP0550550B1 (https=)
JP (1) JP2831464B2 (https=)
KR (1) KR100200438B1 (https=)
AT (1) ATE245157T1 (https=)
AU (1) AU652187B2 (https=)
CA (1) CA2092431C (https=)
CY (1) CY2387B1 (https=)
DE (1) DE69133295T2 (https=)
DK (1) DK0550550T3 (https=)
ES (1) ES2203609T3 (https=)
GB (1) GB9020927D0 (https=)
IE (1) IE913352A1 (https=)
MX (1) MX9101236A (https=)
NZ (1) NZ239915A (https=)
PT (1) PT99028B (https=)
TW (1) TW240227B (https=)
WO (1) WO1992005174A1 (https=)
ZA (1) ZA917606B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9121170D0 (en) * 1991-10-05 1991-11-20 Smithkline Beecham Plc Pharmaceuticals
US5344831A (en) * 1992-01-31 1994-09-06 Nisshin Flour Milling Co., Ltd. Diazabicyclo derivatives
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
US5514690A (en) * 1992-11-17 1996-05-07 E. R. Squibb & Sons, Inc. Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
HRP20041132A2 (en) 2002-04-29 2006-07-31 Actelion Pharmaceuticals Ltd. 7-aryl-3, 9-diazabicyclo (3.3.1) non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
EP1678176A1 (en) * 2003-10-13 2006-07-12 Actelion Pharmaceuticals Ltd. Diazabicyclononene derivatives and their use as renin inhibitors
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
WO2005123718A2 (en) 2004-06-15 2005-12-29 Pfizer Japan Inc. Benzimidazolone carboxylic acid derivatives
AP2007004067A0 (en) 2005-02-22 2007-08-31 Pfizer Oxyindole derivatives as 5HT4 receptor agonists
US8129538B1 (en) 2007-03-28 2012-03-06 Takeda Pharmaceutical Company Limited Renin inhibitors
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
JP2025530213A (ja) 2022-09-09 2025-09-11 ミリックス ファーマ リミテッド Ｎｍｔ阻害剤を含む抗体薬物コンジュゲート及びその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions
US4920227A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Benzobicyclic carboxamide 5-HT3 antagonists
US4920219A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents

Also Published As

Publication number Publication date
DE69133295T2 (de) 2004-03-18
ES2203609T3 (es) 2004-04-16
JP2831464B2 (ja) 1998-12-02
IE913352A1 (en) 1992-04-08
CA2092431A1 (en) 1992-03-27
EP0550550B1 (en) 2003-07-16
AU652187B2 (en) 1994-08-18
AU8624491A (en) 1992-04-15
CY2387B1 (en) 2004-09-10
HK1012356A1 (en) 1999-07-30
MX9101236A (es) 1992-05-04
ATE245157T1 (de) 2003-08-15
WO1992005174A1 (en) 1992-04-02
NZ239915A (en) 1993-11-25
PT99028B (pt) 1999-02-26
JPH06501256A (ja) 1994-02-10
TW240227B (https=) 1995-02-11
EP0550550A1 (en) 1993-07-14
KR100200438B1 (ko) 1999-06-15
PT99028A (pt) 1993-10-29
CA2092431C (en) 2002-12-10
KR930702345A (ko) 1993-09-08
DE69133295D1 (de) 2003-08-21
DK0550550T3 (da) 2003-09-08
ZA917606B (en) 1992-09-30

Similar Documents

Publication Publication Date Title
GB9020927D0 (en) Pharmaceuticals
ES2054826T3 (es) Peptidos con actividad inhibidora de colagenasa.
GR3002867T3 (en) Naphthalene derivatives, process for their preparation and pharmaceutical compositions containing the same
NO911158L (no) Hydantoinderivater.
HUT68721A (en) Benzofuran and benzizoxazole derivatives, pharmaceutical composition containing said compounds as active agent and process for preparing them
SE8604950L (sv) Demensforbettrande och terapeutiska medel
YU48089B (sh) Novi derivati tetrazola i postupak za njihovo pripremanje
ATE285410T1 (de) Naphthyridinderivate oder salze davon
ATE144501T1 (de) Tetrazolamide als acat inhibitoren
SE8106441L (sv) 2,6-c-dimetyltyrosin?721-d-aminosyra?722-omega-aminokapronsyra-och-gamma-aminosmorsyraderivat av metioninencefalin
SE8008555L (sv) Tioetylamidderivat
ES8305359A1 (es) Un procedimiento para la preparacion de benzamitas sustituidas.
ATE93861T1 (de) Synthese von beta-lactamverbindungen.
ATE34173T1 (de) Thiazolderivate als h2-rezeptor-antagonisten.
DE3264556D1 (en) Sulfimines, their salts and their preparation, and pharmaceutical compositions containing them
AU6161986A (en) New textraoxo compounds
SE8005493L (sv) 4-(haftalenyloxi)piperidin-derivat
SE8207294L (sv) 1,4-tiazankarboxylsyraderivat, deras framstellning och anvendning och kompositioner vari dessa derivat ingar
ES502064A0 (es) Procedimiento de producir amidas ciclicas
PT85635A (en) Process for the preparation of 2-cyano-2-alkoximino-acetamides having a fungicidal effect and of intermediates
ES2061889T3 (es) Nuevos derivados de la 2-aminodecalina y su nucleo.
ATE188470T1 (de) Chinolondisulfide als zwischenverbindungen
ECSP951498A (es) Nuevos derivados de pirrocarbazol case ran 4121/15
DK128892A (da) Benzyletherderivater
FI852465L (fi) Selektiva, biologiskt aktiva 7-oxo- prostacyklin-derivat samt framstaellningsfoerfarande foer dessa samt dessa innehaollande farmaceutiska kompositioner.